| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 51.98% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 06/12/2023 | 143.16% | Alliance Global Partners | $4.5 → $8 | Upgrades | Neutral → Buy |
| 05/25/2023 | 51.98% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 05/19/2023 | 51.98% | HC Wainwright & Co. | $9 → $5 | Maintains | Buy |
| 05/16/2023 | 173.56% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 04/03/2023 | 173.56% | HC Wainwright & Co. | → $9 | Reiterates | → Buy |
| 02/23/2023 | 173.56% | HC Wainwright & Co. | → $9 | Reiterates | → Buy |
| 11/21/2022 | 36.78% | Alliance Global Partners | $11 → $4.5 | Downgrades | Buy → Neutral |
| 07/28/2022 | 173.56% | HC Wainwright & Co. | $8 → $9 | Maintains | Buy |
| 05/10/2022 | 143.16% | HC Wainwright & Co. | $10 → $8 | Maintains | Buy |
| 02/25/2022 | 203.95% | HC Wainwright & Co. | $12 → $10 | Maintains | Buy |
| 08/16/2021 | 264.74% | HC Wainwright & Co. | $16 → $12 | Maintains | Buy |
| 04/15/2021 | 386.32% | HC Wainwright & Co. | $14 → $16 | Maintains | Buy |
| 04/14/2020 | 325.53% | HC Wainwright & Co. | $15 → $14 | Reiterates | → Buy |
| 04/07/2020 | 355.93% | B. Riley Securities | $24 → $15 | Maintains | Buy |
| 11/18/2019 | 355.93% | HC Wainwright & Co. | $1 → $15 | Maintains | Buy |
| 10/31/2019 | -69.6% | HC Wainwright & Co. | $1.5 → $1 | Maintains | Buy |
| 05/28/2019 | -8.81% | Craig-Hallum | → $3 | Initiates Coverage On | → Buy |
What is the target price for Alimera Sciences (ALIM)?
The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $5.00 expecting ALIM to rise to within 12 months (a possible 51.98% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alimera Sciences (ALIM)?
The latest analyst rating for Alimera Sciences (NASDAQ: ALIM) was provided by HC Wainwright & Co., and Alimera Sciences reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Alimera Sciences (ALIM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alimera Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alimera Sciences was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
Is the Analyst Rating Alimera Sciences (ALIM) correct?
While ratings are subjective and will change, the latest Alimera Sciences (ALIM) rating was a reiterated with a price target of $0.00 to $5.00. The current price Alimera Sciences (ALIM) is trading at is $3.29, which is within the analyst's predicted range.
